Arteriovenous fistula as a nephroprotective intervention in advanced CKD: Scientific discovery and explanation, and the evaluation of interventions

Nephrology Dialysis Transplantation

Volumn 30, Issue 12, 2015, Pages 1939-1941

  Locatelli, Francesco ^a   Zoccali, Carmine ^b  

^a A MANZONI HOSPITAL   (Italy)

^b CNR   (Italy)

Author keywords

[No Author keywords available]

Indexed keywords

ARTERIOVENOUS FISTULA; CHRONIC KIDNEY DISEASE; DISEASE COURSE; GLOMERULUS FILTRATION RATE; HEART LEFT VENTRICLE FUNCTION; HEMODYNAMICS; HUMAN; KIDNEY BLOOD FLOW; PRIORITY JOURNAL; PROTEINURIA; PULMONARY HYPERTENSION; RENAL PROTECTION; REPERFUSION INJURY; REVIEW; VASOCONSTRICTION;

EID: 84959375433     PISSN: 09310509     EISSN: 14602385     Source Type: Journal    
DOI: 10.1093/ndt/gfv281     Document Type: Review

References (17)

1. Taguma Y, Kitamoto Y, Futaki G et al. Effect of captopril on heavy proteinuria in azotemic diabetics. N Engl J Med 1985; 313: 1617-1620
2. Bolignano D, Rastelli S, Agarwal R et al. Pulmonary hypertension in CKD. Am J Kidney Dis 2013; 61: 612-622
3. Vandenbroucke JP. Observational research, randomised trials, and two views of medical science. PLoS Med 2008; 5: e67
4. Przyklenk K, Bauer B, Ovize M et al. Regional ischemic preconditioning protects remote virgin myocardium from subsequent sustained coronary occlusion. Circulation 1993; 87: 893-899
5. Botker HE, Kharbanda R, Schmidt MR et al. Remote ischaemic conditioning before hospital admission, as a complement to angioplasty, and effect on myocardial salvage in patients with acute myocardial infarction: A randomised trial. Lancet 2010; 375: 727-734
6. Zarbock A, Schmidt C, Van AH et al. Effect of remote ischemic preconditioning on kidney injury among high-risk patients undergoing cardiac surgery: A randomized clinical trial. JAMA 2015; 313: 2133-2141
7. Mahgoub MA, Guo JH, Gao SP et al. Hyperdynamic circulation of arteriovenous fistula preconditions the heart and limits infarct size. Ann Thorac Surg 1999; 68: 22-28
8. Burchell AE, Lobo MD, Sulke Net al. Arteriovenous anastomosis: is this the way to control hypertension? Hypertension 2014; 64: 6-12
9. Lobo MD, Sobotka PA, Stanton A et al. Central arteriovenous anastomosis for the treatment of patientswith uncontrolled hypertension (theROXCONTROL HTN study): A randomised controlled trial. Lancet 2015; 385: 1634-1641
10. Korsheed S, Eldehni MT, John SG et al. Effects of arteriovenous fistula formation on arterial stiffness and cardiovascular performance and function. Nephrol Dial Transplant 2011; 26: 3296-3302
11. Winternitz SR, Oparil S. Importance of the renal nerves in the pathogenesis of experimental hypertension. Hypertension 1982; 4: III108-III114
12. Epstein FH, Post RS, McDowell M. The effects of an arteriovenous fistula on renal hemodynamics and electrolyte excretion. J Clin Invest 1953; 32: 233-241
13. Hilton JG, Kanter DM, Hays DR et al. The effect of acute arteriovenous fistula on renal functions. J Clin Invest 1955; 34: 732-736
14. Golper TA, Hartle PM, Bian A. Arteriovenous fistula creation may slow estimated glomerular filtration rate trajectory. Nephrol Dial Transplant 2015; 30: 2014-2018
15. Korsheed S, Crowley LE, Fluck RJ et al. Creation of an arteriovenous fistula is associated with significant acute local and systemic changes in microvascular function. Nephron Clin Pract 2013; 123: 173-179
16. Li L, Astor BC, Lewis J et al. Longitudinal progression trajectory of GFR among patients with CKD. Am J Kidney Dis 2012; 59: 504-512
17. Locatelli F, Del Vecchio L. Protein restriction: A revisited old strategy with new opportunities? Nephrol Dial Transplant 2014; 29: 1624-1627